North America Biosurgery Market (2019-2025)
The North America Biosurgery Market would witness market growth of 6.4% CAGR during the forecast period (2019-2025).
Biosurgery is a biotherapy involving the introduction of life, disinfected maggots into the non-healing skin and soft tissue wound of a human or animal. It helps to clean out the necrotic tissue within a wound and disinfection. It was long believed that the debridement was selective on necrotic tissue, but new literature has questioned that belief. Fibrin and collagen sealant, hemostats, soft tissue attachments, adhesion barriers, and bone morphogenetic proteins are among the prevalent biosurgery products. The extensive investments by governments have improved healthcare facilities; this would significantly expand the market. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.
The scenario of the biosurgery market across American countries is influenced by the increased sport-related injuries and spinal injuries. Certain factors driving the market growth are the rise in per capita healthcare spending, the increase in the number of surgeries due to an increase in the obese population along with lifestyle disorders. Despite the numerous benefits, market growth is still hampered by factors such as high costs, and consumers ' growing preference for minimally invasive surgery as opposed to conventional surgery.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
Biosurgery is a biotherapy involving the introduction of life, disinfected maggots into the non-healing skin and soft tissue wound of a human or animal. It helps to clean out the necrotic tissue within a wound and disinfection. It was long believed that the debridement was selective on necrotic tissue, but new literature has questioned that belief. Fibrin and collagen sealant, hemostats, soft tissue attachments, adhesion barriers, and bone morphogenetic proteins are among the prevalent biosurgery products. The extensive investments by governments have improved healthcare facilities; this would significantly expand the market. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.
The scenario of the biosurgery market across American countries is influenced by the increased sport-related injuries and spinal injuries. Certain factors driving the market growth are the rise in per capita healthcare spending, the increase in the number of surgeries due to an increase in the obese population along with lifestyle disorders. Despite the numerous benefits, market growth is still hampered by factors such as high costs, and consumers ' growing preference for minimally invasive surgery as opposed to conventional surgery.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
- US
- Canada
- Mexico
- Rest of North America
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biosurgery Market, by Application
1.4.2 North America Biosurgery Market, by Product
1.4.3 North America Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. NORTH AMERICA BIOSURGERY MARKET BY APPLICATION
4.1 North America General Surgeries Market by Country
4.2 North America Orthopedic Surgeries Market by Country
4.3 North America Neurological Surgeries Market by Country
4.4 North America Cardiovascular Surgeries Market by Country
4.5 North America Other Application Biosurgery Market by Country
CHAPTER 5. NORTH AMERICA BIOSURGERY MARKET BY PRODUCT
5.1 North America Surgical sealants Biosurgery Market by Country
5.2 North America Soft Tissue Attachments Biosurgery Market by Country
5.3 North America Adhesion Barriers Biosurgery Market by Country
5.4 North America Hemostatic Agents Biosurgery Market by Country
5.5 North America Bone Graft Substitutes Biosurgery Market by Country
5.6 North America Others Biosurgery Market by Country
CHAPTER 6. NORTH AMERICA BIOSURGERY MARKET BY COUNTRY
6.1 US Biosurgery Market
6.1.1 US Biosurgery Market by Application
6.1.2 US Biosurgery Market by Product
6.2 Canada Biosurgery Market
6.2.1 Canada Biosurgery Market by Application
6.2.2 Canada Biosurgery Market by Product
6.3 Mexico Biosurgery Market
6.3.1 Mexico Biosurgery Market by Application
6.3.2 Mexico Biosurgery Market by Product
6.4 Rest of North America Biosurgery Market
6.4.1 Rest of North America Biosurgery Market by Application
6.4.2 Rest of North America Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biosurgery Market, by Application
1.4.2 North America Biosurgery Market, by Product
1.4.3 North America Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. NORTH AMERICA BIOSURGERY MARKET BY APPLICATION
4.1 North America General Surgeries Market by Country
4.2 North America Orthopedic Surgeries Market by Country
4.3 North America Neurological Surgeries Market by Country
4.4 North America Cardiovascular Surgeries Market by Country
4.5 North America Other Application Biosurgery Market by Country
CHAPTER 5. NORTH AMERICA BIOSURGERY MARKET BY PRODUCT
5.1 North America Surgical sealants Biosurgery Market by Country
5.2 North America Soft Tissue Attachments Biosurgery Market by Country
5.3 North America Adhesion Barriers Biosurgery Market by Country
5.4 North America Hemostatic Agents Biosurgery Market by Country
5.5 North America Bone Graft Substitutes Biosurgery Market by Country
5.6 North America Others Biosurgery Market by Country
CHAPTER 6. NORTH AMERICA BIOSURGERY MARKET BY COUNTRY
6.1 US Biosurgery Market
6.1.1 US Biosurgery Market by Application
6.1.2 US Biosurgery Market by Product
6.2 Canada Biosurgery Market
6.2.1 Canada Biosurgery Market by Application
6.2.2 Canada Biosurgery Market by Product
6.3 Mexico Biosurgery Market
6.3.1 Mexico Biosurgery Market by Application
6.3.2 Mexico Biosurgery Market by Product
6.4 Rest of North America Biosurgery Market
6.4.1 Rest of North America Biosurgery Market by Application
6.4.2 Rest of North America Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 NORTH AMERICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 US BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 US BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 US BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 US BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 US BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 US BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 CANADA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 CANADA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 CANADA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 CANADA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 CANADA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 CANADA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 MEXICO BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 MEXICO BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 MEXICO BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 MEXICO BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 MEXICO BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 MEXICO BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 REST OF NORTH AMERICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 REST OF NORTH AMERICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 60 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 61 KEY INFORMATION – MEDTRONIC PLC
TABLE 62 KEY INFORMATION – PFIZER, INC.
TABLE 63 KEY INFORMATION – STRYKER CORPORATION
TABLE 64 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 65 KEY INFORMATION – SANOFI S.A.
TABLE 66 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 67 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 68 KEY INFORMATION – CSL LIMITED
TABLE 1 NORTH AMERICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 US BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 US BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 US BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 US BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 US BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 US BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 CANADA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 CANADA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 CANADA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 CANADA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 CANADA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 CANADA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 MEXICO BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 MEXICO BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 MEXICO BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 MEXICO BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 MEXICO BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 MEXICO BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 REST OF NORTH AMERICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 REST OF NORTH AMERICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 60 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 61 KEY INFORMATION – MEDTRONIC PLC
TABLE 62 KEY INFORMATION – PFIZER, INC.
TABLE 63 KEY INFORMATION – STRYKER CORPORATION
TABLE 64 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 65 KEY INFORMATION – SANOFI S.A.
TABLE 66 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 67 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 68 KEY INFORMATION – CSL LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
